Biomedical Engineering Reference
In-Depth Information
196. Qi, L. F., Xu, Z. R., Li, Y., Jiang, X., and Han, X. Y. 2005.
In vitro
effects of chitosan nanoparticles
on proliferation of human gastric carcinoma cell line MGC803 cells.
World J Gastroentero
11: 5136-5141.
197. Tobio, M., Sanchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., and Alonso, M. J. 2000. The
role of PEG on the stability in digestive fluids and
in vivo
fate of PEG-PLA nanoparticles follow-
ing oral administration.
Colloid Surf B
18: 315-323.
198. Feng, S. S. and Chien, S. 2003. Chemotherapeutic engineering: Application and further devel-
opment of chemical engineering principles for chemotherapy of cancer and other diseases.
Chem Eng Sci
58: 4087-4114.
199. Florence, A. T. 1997. The oral absorption of micro and nanoparticles: Neither exceptional nor
unusua.
Pharm Res
14: 259-266.
200. Marianne, R., Dagmar, F., and Thomas, K. 1998. Surface-modified biodegradable albumin
nano- and microspheres. II: Effect of surface charges on
in vitro
phagocytosis and biodistribu-
tion in rats.
Eur J Pharm Biopharm
46: 255-263.
201. Wang, J., Kozo, T., Tsuneji, N., and Yoshie, M. 2003. Pharmacokinetics and antitumor effects of
vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and choles-
terol.
Int J Pharm
251: 13-21.
202. Fan, F., Marc, D., Dai, F., Michael, L., David, A. B., Torchilin, V. P., and Jain, R. K. 1995. Vascular
permeability in a human tumor xenograft:molecular size dependence and cutoff size.
Cancer
Res
55: 3752-3756.
203. Moghimi, S. M., Hunter, A. C., and Murray, J. C. 2001. Long-circulating and target-specific
nanoparticles: Theory to practice.
Pharmacol Rev
53: 283-318.
204. Kondo, N., Iwao, T., Kikuchi, M., Shu, H., Yamanouchi, K., Yokoyama, K., Ohyama, K., and
Ogyu, S. 1993. Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in exper-
imental animals.
Biol Pharm Bull
16: 796-800.
205. Kreuter, J. 1991. Peroral administration of nanoparticles.
Adv Drug Deliv Rev
7: 71-86.
206. Gary, G. L. and Kenneth, C. C. 1995. Particle size reduction for improvement of oral bioavail-
ability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in
beagle dogs.
Int J Pharm
125: 91-97.
207. Williams, J., Lansdown, R., Sweitzer, R., Romanowski, M., LaBell, R., Ramaswami, R., and
Unger, E. 2003. Nanoparticle drug delivery system for intravenous delivery of topoisomerase
inhibitors.
J Control Release
91: 167-172.
208. Chouly, C., Pouliquen, D., Lucet, I., Jeune, J. J., and Jallet, P. 1996. Development of superparamag-
netic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution.
J Microencapsulation
13: 245-255.
209. Qi, L. F. and Xu, Z. R. 2006.
In vivo
antitumor activity of chitosan nanoparticles.
Bioorg Med
Chem Lett
16: 4243-4245.
210. Prabhu, R. and Balasubramanian, K. A. 2001. A novel method of preparation of small intestinal
CTE brush border membrane vesicles by polyethylene glycol precipitation.
Anal Biochem
289: 157-161.
211. Kessler, M., Acuto, O., Storelli, C., Murer, H., Ller, M. M., and Semenza, G. 1978. A moded
procedure for the rapid preparation of efficiently transporting vesicles from small intestinal
brush border membranes: their use in investigating some properties of D-glucose and choline
transport systems.
Biochim Biophy Acta
506: 136-154.
212. Cho, S., Park, J. H., Yu, J., Lee, Y., Byun, Y., Chung, H. C., Kwon, I. C., and Jeong, S. Y. 2004.
Preparation and characterization of reconstructed small intestinal brush border membranes for
surface plasm on resonance analysis.
Pharm Res
21: 55-60.
213. Kim, K., Cho, S., Park, J. H., Byun, Y., Chung, H., Kwon, I. C., and Jeong, S. Y. 2004. Surface
plasmon resonance studies of the direct interaction between a drug/intestinal brush border
membrane.
Pharm Res
21: 1233-1239.
214. Lee, E., Kim, H. J., Lee, I. H., and Jon, S. Y. 2009.
In vivo
antitumor effects of chitosan-conjugated
docetaxel after oral administration.
J Control Release
140: 79-85.
Search WWH ::
Custom Search